Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dapsone
Cat. No.:
0225LY-0700
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Dapsone is a broad-spectrum antibacterial agent most notably utilized for its effectiveness against Mycobacterium leprae.
Synonym:
DDS; 4,4‘-Sulfonyldianiline; Bis(4-aminophenyl) sulfone; Sulphadione; 4,4'-Diaminodiphenylsulfone; 4-Aminophenyl sulfone; 80-08-0; Diaphenylsulfone; Dapsonum; Diphenasone; Bis(4-aminophenyl) sulfone; Avlosulfon; Bis(p-aminophenyl) sulfone
CAS No.:
80-08-0
Compound CID:
2955
Formula:
C12H12N2O2S
Formula Weight:
248.3
Specification
Relative Density:
1.2701 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dapsone can be used in dermatology and microbiology to investigate its dual anti-inflammatory and antibacterial effects.
Library Information
Target:
Parasite protein
Receptor:
Parasite protein
Pathways:
Metabolism; Immunology/Inflammation; Microbiology/Virology; NF-κB
Plate Number:
AOCL-10
Plate Location:
a7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 201.37 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
10 mg/mL; 40.27 mM
